Down syndrome associated childhood myeloid leukemia with yet unreported acquired chromosomal abnormalities and a new potential adverse marker: dup(1)(q25q44).

Moassass, Faten; Wafa, Abdulsamad; Liehr, Thomas; Al-Ablog, Ayman; Al Achkar, Walid

Moassass, Faten; Wafa, Abdulsamad; Liehr, Thomas; Al-Ablog, Ayman; Al Achkar, Walid.

Afiliação

Moassass F; 1Molecular Biology and Biotechnology Department, Human Genetics Division, Chromosomes Laboratory, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria.
Wafa A; 1Molecular Biology and Biotechnology Department, Human Genetics Division, Chromosomes Laboratory, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria.
Liehr T; 2Jena University Hospital, Institute of Human Genetics, Am Klinikum 1, 07747 Jena, Germany.
Al-Ablog A; 1Molecular Biology and Biotechnology Department, Human Genetics Division, Chromosomes Laboratory, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria.
Al Achkar W; 1Molecular Biology and Biotechnology Department, Human Genetics Division, Chromosomes Laboratory, Atomic Energy Commission of Syria, P.O. Box 6091, Damascus, Syria.

Mol Cytogenet ; 11: 22, 2018.

Article em En | MEDLINE | ID: mdl-29563973

Palavras-chave

AML; Acquired chromosomal abnormalities (ACAs); Clone evolution; Cytogenetics; Down syndrome; Fluorescence in situ hybridization (FISH); Prognostic factors; Trisomy 21

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Cytogenet Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Síria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google